Navigation Links
DrugRisks Center NuvaRing Lawsuit News: Drug Maker May Have Concealed Risks
Date:4/2/2013

New York, NY (PRWEB) April 02, 2013

DrugRisks’ birth control resource center is announcing updated news on the site for women using the vaginal ring contraceptive NuvaRing. Recently added information shows the maker of the device, Organon, may have concealed the risk of dangerous estrogen bursts.

DrugRisks was created to improve the safety of those using popular prescription devices like NuvaRing by providing the latest warnings, recalls, studies and legal news. Visitors can determine if others are experiencing similar side effects and decide if they need legal advice.

Health experts have warned that contraceptive rings like NuvaRing may have higher risks of blood clots than traditional birth control pills. Last year, the New England Journal of Medicine published a study finding vaginal rings could relate to a 2.5 to 3-fold increased risk of blood clots*.

DrugRisks also contains information showing that FDA has received over 5,300 adverse reports for women using NuvaRing devices.** Most common among the side effects were 1,177 cases of pulmonary embolism and 1,155 reports of thrombosis or deep vein thrombosis. In more than 30% of cases, patients required hospitalization, while 3% ended in death**.

Around 1,097 patients have filed a NuvaRing lawsuit so far alleging blood clots, with the cases consolidated to a special federal court in Missouri. The formal case is known as In re: NuvaRing Products Liability Litigation, No. 08-md-1964, JPML, Eastern District Missouri. U.S. District Judge Rodney Sippel, who presides over the federal cases, recently delayed the start of the first NuvaRing trial until October 21, 2013***.

Now, DrugRisk has learned that Judge Sippel entered an order on March 5th allowing patients to introduce a study by Dr. Shelley Ann Tischkau, Ph.D., which finds that NuvaRing maker Organon may have concealed the risk of estrogen bursts in test patients to the FDA, which could contribute to the blood clot risks****.

Anyone who suffered a blood clot, stroke, DVT or pulmonary embolism after using NuvaRing is urged to contact DrugRisks or speak with a lawyer about their legal rights as soon as possible.

Due to the specialized nature of federal MDL drug injury cases, DrugRisks cautions patients to seek a lawyer with experience in this litigation, and only recommends lawyers and law firms who have already handled NuvaRing lawsuits.

Visit http://www.DrugRisks.com today for more information on the research, NuvaRing side effects and litigation news related to NuvaRing and other devices, or to speak with a lawyer.

*nejm.org/doi/full/10.1056/NEJMoa1111840
**adverseevents.com/drugdetail.php?AEDrugID=4584&BrandName=NUVARING
***http://cdn.aboutlawsuits.com/wp-content/uploads/2013-03-08-NuvaRing-Order.pdf
****mo.findacase.com/research/wfrmDocViewer.aspx/xq/fac.20130305_0000431.EMO.htm/qx

Read the full story at http://www.prweb.com/releases/nuvaring-side-effects/lawsuit-information/prweb10589445.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisks Adds New Pradaxa Study Alert As Lawsuits Increase
2. DrugRisks Adds Update from First Actos Trial of Patient Alleging Bladder Cancer
3. Lung Cancer Asbestos Victims Center Now Urges Retired Nonsmoker Industrial Workers Who Have Been Diagnosed With Any Type Of Lung Cancer To Call Them About Compensation
4. Mesothelioma Victims Center Urges Family Members With A Parent Diagnosed With Mesothelioma To Call Them For The Contacts Of The Most Skilled Mesothelioma Law Firms
5. The Hearing Center of Lake Charles, Number One Provider of Hearing Aids in Lake Charles LA, Announces New Comparison Guide
6. Rapid Fat Loss
7. How “Final Phase Fat Loss” Helps Men Build Muscle And Burn Fat Fast – Health Review Center
8. Orthopaedic & Spine Institute Opens New Children's Center
9. Mesothelioma Victims Center Now Urges Families Dealing With A Loss From Mesothelioma To Focus On Compensation- Call Them For The Names Of Best Mesothelioma Law Firms
10. Drug Center Adds News on Mirena Lawsuits: Bayer Fighting Move to Federal Court
11. Kessler Foundation scientists receive Consortium of MS Centers grant to study emotional processing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their ... Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. , ... Pro X users can now reveal the media of their split screens with ...
(Date:6/26/2016)... ... ... Quality metrics are proliferating in cancer care, and are derived from many ... the beholder, according to experts who offered insights and commentary in the current issue ... the full issue, click here . , For the American Society of Clinical ...
(Date:6/26/2016)... ... June 26, 2016 , ... ... have been diagnosed with endometriosis. These women need a treatment plan to not ... comprehensive approach that can help for preservation of fertility and ultimately achieving a ...
(Date:6/25/2016)... ... 25, 2016 , ... First Choice Emergency Room , the largest network ... the Medical Director of its new Mesquite-Samuell Farm facility. , “We are pleased ... location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016  Guerbet announced today that ... Supplier Horizon Award . One of ... was recognized for its support of Premier members through ... clinical excellence, and commitment to lower costs. ... this recognition of our outstanding customer service from Premier," ...
(Date:6/23/2016)... 2016 Research and Markets has ... Global Analysis (United States, China, Japan, Brazil, United Kingdom, ... their offering. Surgical ... business planners, provides surgical procedure volume data in a ... an in-depth analysis of growth drivers and inhibitors, including ...
(Date:6/23/2016)... , June 23, 2016 The ... it continues to present great opportunities to investors. Stock-Callers.com ... today: Intrexon Corp. (NYSE: XON ), Vertex ... Inc. (NASDAQ: ARNA ), and Regeneron Pharmaceuticals ... these stocks and receive your complimentary trade alerts at: ...
Breaking Medicine Technology: